SCHEMBL14477221

SCHEMBL14477221

CCOC(C(=O)O)c1ccc(NN=N)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX1 P07099 1/20 0.41
▸ FFAR1 O14842 2/20 0.37
▸ LMNA P02545 3/20 0.35
▸ GAA P10253 1/20 0.35
▸ ATM Q13315 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ KYAT1 Q16773 3/20 0.33
▸ F10 P00742 1/20 0.33
▸ PRSS1 P07477 1/20 0.33
▸ PRSS2 P07478 1/20 0.33
▸ F7 P08709 1/20 0.33
▸ F3 P13726 1/20 0.33
▸ PRSS3 P35030 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ BCHE P06276 1/20 0.33
▸ ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1094337 0.80 KMT2A (0.54) EPHX1LMNAALDH1A1MEN1CYP1A2
SCHEMBL10355170 0.76 ESR1 (0.44) LMNANPSR1ALDH1A1CYP1A2KMT2A
SCHEMBL24327752 0.76 FFAR1 (0.47) EPHX1FFAR1LMNAALDH1A1MEN1
SCHEMBL6504745 0.76 PPARA (0.49) LMNAALDH1A1CYP1A2PPARGPPARA
SCHEMBL2553482 0.76 PPARA (0.49) LMNAALDH1A1CYP1A2PPARGPPARA
SCHEMBL17653645 0.76 PPARA (0.49) LMNAALDH1A1CYP1A2PPARGPPARA
SCHEMBL755552 0.74 MAOA (0.44) EPHX1LMNAGAANPSR1ALDH1A1
SCHEMBL24327731 0.74 HPGD (0.49) LMNAGAANPSR1ALDH1A1MEN1
SCHEMBL24327737 0.74 PPARG (0.49) FFAR1LMNAMEN1KMT2APPARG
SCHEMBL17295981 0.74 HPGD (0.49) LMNAGAANPSR1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130005813-A1 Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field GIULIANI INTERNATIONAL LIMITED (IE) 2013-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130005813-A1 Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field EGFR, ERBB3, FGFR3 EPHX1 3074/4885FFAR1 55/4885LMNA 4225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback